1. Home
  2. BLFS

as of 01-16-2026 3:54pm EST

$24.35
$0.12
-0.49%
Stocks Health Care Medical/Dental Instruments Nasdaq

BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

Founded: 1987 Country:
United States
United States
Employees: N/A City: BOTHELL
Market Cap: 1.2B IPO Year: 1989
Target Price: $32.00 AVG Volume (30 days): 328.0K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.07 EPS Growth: N/A
52 Week Low/High: $19.10 - $29.62 Next Earning Date: 03-02-2026
Revenue: $100,144,000 Revenue Growth: 87.53%
Revenue Growth (this year): 18.45% Revenue Growth (next year): 16.27%

AI-Powered BLFS Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 4 days ago

AI Recommendation

hold
Model Accuracy: 0.00%
0.00%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of BioLife Solutions Inc. (BLFS)

Aebersold Sarah

Chief Human Resources Officer

Sell
BLFS Jan 6, 2026

Avg Cost/Share

$25.59

Shares

241

Total Value

$6,167.19

Owned After

75,765

SEC Form 4

Berard Todd

Chief Marketing Officer

Sell
BLFS Jan 6, 2026

Avg Cost/Share

$25.59

Shares

344

Total Value

$8,802.96

Owned After

132,564

SEC Form 4

Foster Karen A.

Chief Quality and Operations

Sell
BLFS Jan 6, 2026

Avg Cost/Share

$25.59

Shares

335

Total Value

$8,572.65

Owned After

191,984

SEC Form 4

Mathew Aby J.

EVP & Chief Scientific Officer

Sell
BLFS Jan 6, 2026

Avg Cost/Share

$25.59

Shares

405

Total Value

$10,363.95

Owned After

349,350

SEC Form 4

Wichterman Troy

Chief Financial Officer

Sell
BLFS Jan 6, 2026

Avg Cost/Share

$25.59

Shares

990

Total Value

$25,334.10

Owned After

150,746

SEC Form 4

Aebersold Sarah

Chief Human Resources Officer

Sell
BLFS Dec 15, 2025

Avg Cost/Share

$24.46

Shares

713

Total Value

$17,439.98

Owned After

75,765

SEC Form 4

DuRoss Amy

Director

Sell
BLFS Dec 15, 2025

Avg Cost/Share

$24.60

Shares

2,000

Total Value

$49,200.00

Owned After

18,687

SEC Form 4

Aebersold Sarah

Chief Human Resources Officer

Sell
BLFS Dec 9, 2025

Avg Cost/Share

$25.13

Shares

233

Total Value

$5,855.29

Owned After

75,765

SEC Form 4

Berard Todd

Chief Marketing Officer

Sell
BLFS Dec 9, 2025

Avg Cost/Share

$25.13

Shares

358

Total Value

$8,996.54

Owned After

132,564

SEC Form 4

Foster Karen A.

Chief Quality and Operations

Sell
BLFS Dec 9, 2025

Avg Cost/Share

$25.13

Shares

519

Total Value

$13,042.47

Owned After

191,984

SEC Form 4

Share on Social Networks: